Rigel Announces Fourth Quarter and Year End 2017 Financial Results and Provides Company Update

Go back to Rigel Announces Fourth Quarter and Year End 2017 Financial Results and Provides Company Update

Rigel Pharma (RIGL) Misses Q4 EPS by 5c

March 6, 2018 4:16 PM EST

Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.

... More